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In  the  two  preceding articles  of  this  series it has  been  shown  by 
Cecil  and  Steffen  (1)  that  monkeys  may  be  immunized  against 
pneumococcus pneumonia by subcutaneous or intravenous injections 
of pneumococcus vaccine.  Inasmuch as rather large doses of vaccine 
were required  to  obtain  complete immunity by subcutaneous  injec- 
tions  it  seemed  desirable  to  investigate  the  chemical  nature  of 
pneumococcus  antigen  with  the  hope  that  some  method  might  be 
devised for separating the immunizing fraction from the toxic fraction 
of  the  microorganism  and  thereby  provide  a  more  practical  agent 
for prophylactic vaccination against  pneumonia  in man. 
Methods. 
Most of the antigens  tested in this study were prepared from a highly virulent 
strain  of  Pneumococcus  Type I.  Later on, in order to corroborate the results 
obtained with  Pneumococcus  Type I,  some  experiments were also  carried out 
with Pneumococcus Types II and III. 
The experiments were all performed on white mice.  The vaccines and antigens 
were in every instance administered subcutaneously in a volume of 0.5 cc.  When 
two injections of vaccine, or antigen,  were administered,  an interval of 6 or 7 days 
elapsed  between the two injections.  When three or four injections of antigen 
were given the interval between the injections was 3 or 4 days.  The immunity 
* This work also received financial aid from the Influenza Fund of the Metro- 
politan Life Insurance Company, New York. 
t Preliminary reports on this investigation were presented at  the New York 
meeting of the American Chemical Society on September 9, 1921, and before the 
New  York  Pathological Society in  November,  1921 (Perlzweig,  W.  A.,  Proc. 
New York Path. Soe., 1921, xxi, N. S., 133). 
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of the vaccinated mice was usually tested 9 to 10 days after the last injection of 
antigen by inoculating them intraperitoneally with various dilutions of a broth 
culture of the homologous type of pneumococcus.  The culture was diluted with 
plain broth and the volume injected was invariably 0.5  cc.  The cultures were 
carefully controlled by examination of stained smears and agglutination and bile 
solubility  tests.  Each  experiment  was  controlled  by  injecting  unvaccinated 
mice intraperitoneally with one or more lethal doses of pneumococcus culture 
(0.0000001 and 0.00000001 cc.).  All of these control mice, a total of 138, without 
a single exception, died in less than 72 hours and pneumococci were found in the 
peritoneal exudate of each of them.  In view of the invariably high virulence of 
the strains employed each survival among the  experimental mice must be re- 
garded as significant  and showing  the production of definite  immunity by the 
antigen in question.  A mouse was counted a  survival ff it lived for 5 days or 
more after the inoculation of the virulent culture.  Usually the mice remained 
under observation for 7  to 10 days after the inoculation.  Each dead mouse was 
dissected and smears from the peritoneal exudate were examined for pneumococci. 
In cases of doubt cultures were made on blood agar plates. 
I.  Immunization  with  a  Saline  Suspension  of Killed  Pneumococcus 
Type I. 
It was first established  that  small  doses  of a  saline  suspension  of 
Pneumococcus Type I, killed by heating  at 60°C.  for 1 hour,  induce 
immunity in mice against  subsequent  infection.  The importance  of 
giving a  small injection  of vaccine,  followed  1 week later by a  larger 
dose, is demonstrated  in the following two experiments. 
Experiment /.--Nine mice received each  a  single  subcutaneous  injection  of 
700 million  (0.5 cc.)  Pneumococcus Type I  saline  vaccine.  10 days later they 
were injected intraperitoneally with a virulent culture of Pneumococcus Type I. 
No.  of  mice.  Culture. 
CCo 
O. 000001 
O. 00001 
O. 0001 
Died.  S~dv~. 
Experiment 2.--Sixteen mice were  each  injected  with  100  million  (0.5  cc.) 
Pneumococcus Type I saline vaccine.  7 days later they received a second dose of 
700 million each.  10 days after the last injection of vaccine they were all inoc- 
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No. of mice.  Culture.  Died.  Survived. 
¢,C° 
0.000001 
0.00001 
0.0001 
0.001 
0.01 
0.1 
A moderate immunity was induced by one subcutaneous injection 
of vaccine (Experiment 1), but a much higher degree of immunity was 
obtained when two injections were given. 
Wadsworth (2) found recently in studying the same question that 
it took no less than six injections of 6 billion  each of killed pneumo- 
cocci to protect white mice against an infecting dose of 0.001 cc. of a 
culture of Pneumococcus  Type I with about the same virulence as that 
of the strain used in these experiments.  This divergence between the 
observations of Wadsworth and our own afford some support to the 
contention of Much (3)  that very small initial doses of vaccine are 
essential to the development of a high degree of immunity. 
II.  Immunization  with  the  Protein  Fraction  of  the  Pneumococcus. 
The  immunizing properties  of the  protein fraction of  the pneu- 
mococcus were studied next.  In order to alter the chemical nature of 
the proteins as little as possible  the following methods of separation 
were used. 
(a)  Rowland's  Method  (4).--Moist  sediments  of  living  pneumo- 
cocci were thoroughly mixed with  twice their  weight of anhydrous 
sodium sulfate and alternately frozen and thawed at 37°C. for several 
days.  Sufficient water was added to make a  saturated solution of 
sodium sulfate at 37°C.  The precipitated protein was washed with 
additional sodium sulfate solution, redissolved in very dilute (0.01 N) 
sodium carbonate solution, and freed of the adhering salt by dialysis. 
As in Rowland's study of the plague bacillus the resulting product 
was found to be chiefly nucleoprotein as shown by the presence of 
organic phosphorus and of the purine bases,  guanine and adenine, on 
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through a  diatomaceous earth filter  (Mandler),  tested for sterility, 
and inoculated into mice  to determine its antigenic value.  In vac- 
cinating mice with the  various  fractions  and  extracts  of  pneumo- 
coccus  the  dosage  was  determined  by  the  concentration  of  the 
bacterial suspension from which the fraction had been derived;  for 
example,  if  the  original  suspension  contained  100  billion  pneu- 
mococci per  cc., mice which received 0.1  cc.  of the protein fraction 
were recorded as having received 10 billion pneumococci. 
Experiment 3.--Eleven  mice each received two  subcutaneous doses of  an 
alkaline solution of Pneumococcus Type I protein, corresponding to 200 million 
and 4 billion pneumococci  respectively.  10 days after the second  dose, which was 
given 7 days after the first, the mice were injected intraperitoneally with a broth 
culture of virulent Pneumococcus  Type I. 
No. of mice.  Culture.  Died.  Survived. 
6c. 
4  0.0001  0  4 
3  O. 001  1  2 
4  0.01  1  3 
(b)  Solution of Pneumococci in Bile Salts.--The property of pneu- 
mococci to dissolve in bile and in solutions of bile salts was utilized 
for the further study of pneumococcus antigen.  To saline suspensions 
of Pneumococcus Type  I  sodium choleate was  added  to make a  1 
per cent solution, also 0.2 per cent disodium phosphate, and the mix- 
ture incubated at 37°C. for 2 to 4 hours, until solution of the pneumo- 
cocci  was  complete  or  nearly  so.  The  undissolved  material  was 
separated by centrifugalization and the supernatant fluid thrown into 
nine volumes of 95 per cent alcohol.  The abundant white precipitate 
was allowed to settle over night, filtered off, and washed free of the 
bile salts with 90 per cent alcohol.  The same nucleoprotein charac- 
teristics were found in this substance as in that obtained by Rowiand's 
method.  It  is  soluble  in  water  and  in  slightly alkaline  solutions, 
coagulated by boiling in the presence of a little acid, contains organic 
phosphorus and purine bases, and responds to all protein color reac- 
tions.  A slightly alkaline filtered solution was used in the following 
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Experiment 4.--Nine mice were each injected subcutaneously with a protein 
solution obtained from a bile salt  solution of Pneumococcus Type I, the  dose 
corresponding to 2 billion pneumococci.  10 days later the mice were inoculated 
intraperitoneally with a broth culture of virulent Pneumococcus  Type I. 
No. of mice.  Culture, 
CC. 
0.00001 
0.0001 
0.001 
Died.  Survived. 
From these experiments it will be seen that the antigen is either a 
part of the protein fraction of the pneumococcus or else is some sub- 
stance attached to it. 
IIL  Immunization  with Proteolytic  and Autolytic  Cleavage Products. 
Rosenow  (5)  claims  to have  shown  that  autolyzed pneumococci 
contained an antigen.  Rowland (4)  showed that his plague bacillus 
nucleoprotein lost  its  toxic properties  and  none  of its  immunizing 
properties if permitted to autolyze for as long as 40 days.  Jobling 
and  Strouse  (6)  showed  that  pneumococcus  extracts  obtained  by 
digestion  with  leucoprotease  raised  the  opsonic  index  in  rabbits 
considerably.  Hirschfelder (7) digested cultures of pneumococci with 
pancreatin for  15  minutes and was able to  confer active immu~ty 
upon rabbits  by injecting the acid filtrates from these digests.  So 
far as the writers are aware Hirschfelder has not reported any further 
studies along this line since  1912.  The above indications  that  the 
antigen appears to be resistant to proteolytic ferments raises the time- 
honored question:  Is antigen necessarily of protein nature?  It will 
be  remembered  that  Jacoby's  "protein-free"  ricin  was  shown  by 
Osborne, Mendel, and Harris  (8)  to be albumin-like in nature, when 
they demonstrated its digestibility with trypsin and consequent loss 
of antigenic property.  In  the following experiments it  was  estab- 
lished  that  prolonged  digestion  with  trypsin  does  not  destroy the 
pneumococcus antigen.  Protein  fractions of pneumococci prepared 
as described above either by bile salt solution and precipitation with 
alcohol or by Rowland's sulfate method were digested with trypsin 
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the  presence  of  chloroform.  The  latter  was  used  for  the  double 
purpose  of preserving  the  digest  and  of removing  the  effects of the 
lipoidal  antiferments  (Jobling  and  Strouse  (6)). z  The progress of 
digestion was followed by determinations of non-protein nitrogen by 
Greenwald's  trichloroacetic  acid  method  of  precipitation  (9)  and 
Folin's micro Kjeldahl method  (10).  It was  found that alkaline  or 
acid filtrates of such digests in which the non-protein nitrogen reached 
85  per  cent  of  the  total  nitrogen  retained  the  original  immunizing 
effect on white mice. 
Experiment 5.--A  solution  of  Pneumococcus  Type I  protein,  obtained  by 
dissolving  pneumococci  in  sodium  choleate, precipitating with alcohol,  and re- 
dissolving  in  distilled  water,  was digested  with trypsin for 4 days and gave a 
Non-protein nitrogen 
ratio of 57 per cent.  The total nitrogen in the filtrate was 
Total nitrogen 
25.2 mE. per 100 cc., of which  1 cc. represented 40 billion pneumococci.  One 
dose, corresponding  to 1 billion  pneumococci,  was administered subcutaneously 
to each of six mice, which were inoculated intraperitoneally 10 days later with a 
virulent Pneumococcus Type I culture. 
No.  of  mice.  Culture.  Died.  Survived. 
cc. 
3  0.000001  2  1 
3  0.00001  1  2 
Experiment 6.--In this experiment the same  solution as above was used but 
Non-protein nitrogen 
in  this instance it was digested  for 25 days.  The  Total nitrogen  ratio in 
the filtrate was 80 per cent.  Six mice were each injected subcutaneously with 
the  equivalent of 2 billion  pneumococci.  10 days later they were inoculated 
intraperitoneally with a culture of virulent Pneumococcus Type I. 
No. of mice.  Culture. 
cc. 
0.000001 
0.00001 
Died.  Survlvcd. 
In another experiment a Pneumococcus Type I protein, obtained by 
Rowland's method, was used.  The digestion with trypsin was in this 
instance continued for 21  days. 
l  Jobling and Strouse (6),  p. 862. WILLIAM  A.  PERLZWEIG  AND  GUSTAV  I.  STEleFEN  169 
Experiment 7.--Ten mice were injected subcutaneously with two doses of this 
preparation, equivalent to  200 million and 4,000 million respectively of killed 
pneumococci.  The interval between the injections was 7 days.  11 days after the 
last injection of antigen the mice  were inoculated intraperitoneally with a culture 
of virulent Pneumococcus  Type I. 
No. of mice.  Culture.  Died.  Survived. 
CO. 
10  0.01  2  8 
Autolytic digests of pneurnococci were also tested in the same way, 
with  similar  results.  But  the  digestion  of  bacterial  protein  by 
autolysis is  so much slower than  that by proteolytic enzymes  that 
the process cannot be considered advantageous. 
Hirschfelder's method of obtaining bacterial antigens was carried 
out with some modifications.  Instead of using cultures for digestion 
with trypsin, saline suspensions of freshly centrifugalized pneumococci 
were used.  The suspensions were made alkaline with sodium carbon- 
ate and sodium phosphate to the reaction of pH 7.6  to 8.0.  0.2 per 
cent of a 1: 1 mixture of trypsin (purified, Parke, Davis and Company) 
and holadin, an extract of the pancreatic enzymes (Fairchild Brothers 
and  Foster),  was  added.  Holadin  was  used  because  of  its  good 
lipolytic properties,  with  the  object  of lessening the  possible  anti- 
tryptic effects of the bacterial fats and lipoids.  Chloroform was also 
added for the same reason and in addition to act as a  preservative. 
The digestion was permitted to continue for 18 hours at 37°C.,  the 
undigested  portion  was  separated  by  centrifugalizafion,  and  the 
supernatant fluid was carefully acidified with dilute hydrochloric acid 
until  the  maximum  precipitation  of  the  alkali  metaproteins  was 
effected.  The precipitate was permitted to settle for several hours, 
removed  by  centrifugalization,  and  the  supernatant  fluid  filtered 
through a  Mandler filter.  The resulting filtrate contained only 25 
per cent of the original nitrogen of the bacterial suspension,  all  of 
which  was  in  the  non-coagulable  state.  Precipitation  and  color 
reactions showed that amino-acids, polypeptides, and proteoses were 
present in  this  filtrate.  The  presence  of proteoses  was  shown  by 
precipitation  tests  with  trichloroacetic and picric acids.  The pres- 
ence of amino-acids was ascertained by a positive ninhydrin reaction. 170  STUDIES  ON  PNEUMOCOCCUS  IMMUNITY.  III 
The biuret, Millon, and xanthoproteic reactions were likewise positive. 
The biuret test was of the pink-violet color, indicative chiefly of the 
lower peptones and polypeptides.  It was possible to obtain with this 
filtrate  a  high  grade  of  immunity  in  mice  against  Pneumococcus 
Type I. 
Experiment 8.--In this experiment the mice received two subcutaneous doses of 
antigen 7 days apart.  10 days after the second injection the mice were inoculated 
intraperitoneally with a virulent Pneumococcus  Type I  culture as in preceding 
experiments. 
Dose of antigen in 
millions  Culture.  No. of mice.  Died.  Survived, 
of pneumococd. 
cc. 
140 +  700  0.00001  4  3  1 
140 +  1,400  0.00001  6  2  4 
In the next experiment larger doses of antigen were employed with 
excellent results. 
Experiment 9.-- 
Dose of antigen in 
millions  Culture.  No. of mice.  Died.  Survived. 
of pneumococci. 
140 +  1,400  0.0001  5  0  5 
140 +  2,800  0.001  5  0  5 
In  the  following experiment  three  or  four  doses  of  antigen  were 
given  3  to  4  days  apart  and  a  still  higher  grade  of immunity was 
produced in the mice. 
Experiment 10.-- 
Dose of antigen in millions  Culture.  No. of mice.  Died.  Survived. 
of pneumocoeci. 
cc. 
175 +  350 +  700  0.001  5  0  5 
175 +  350 +  700 -]- 1,400  0.01  5  2  3 
175 +  350 +  700 +  1,400  0.02  4  1  3 
A  single dose of antigen, even when very large, was not so effective 
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Experiment 11.-- 
Dose of antigen in 
millions  Culture.  No. of mice.  Died.  Survived. 
of pneumococci. 
5,600 
5,600 
8,500 
17,000 
25,500 
CC. 
0.01 
0.05 
0.001 
0.001 
0.001 
These experiments show that with several smaller injections of this 
antigen immunity against as much as 0.02  cc. of culture of virulent 
Pneumococcus Type  I  could  be  obtained.  The  degree of  the  im- 
munity can be  appreciated  by  the realization  that 0.02  cc.  of  the 
culture  was  equivalent  to  several  hundred  thousand  lethal  doses. 
The single administration of one comparatively large amount induces 
practically no protection, as shown in Experiment 1  t. 
In  order to  "deproteinize"  the acid filtrate of  the tryptic digest 
further, a portion of the latter was added to ten volumes of absolute 
alcohol.  The resulting precipitate was collected by centrifugalizafion, 
washed in alcohol, and redissolved in physiological salt solution.  This 
solution gave typical proteose reactions but contained no coagulable 
protein.  When administered to mice subcutaneously in two doses it 
failed to protect them even against small amounts of pneumococcus 
culture. 
Experiment 12.-- 
Dose of antigen in 
millions 
of pneumococci. 
100 +  5,000 
100 +  5,000 
Culture. 
O. 00001 
O. 0001 
No. of mice.  Died.  Survived. 
On the other hand, the alcoholic filtrate, when evaporated in vacuum 
at 35-40°C. to dryness and redissolved in saline afforded considerable 
protection  to  mice,  as  great as  the  ordinary vaccine of heat-killed 
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Experiment 13.-- 
Dose of antigen in millions  Culture.  No. of mice.  Died.  Survived. 
of pneumococci. 
CC. 
100 +  5,000  0.001  3  0  3 
100 +  2,000 +  10,000  0.01  3  1  2 
100 +  2,000 +  10,000  O. 1  3  i  2 
This antigen gave no cross-immunity against  a  culture  of virulent 
Pneumococcus Type II. 
Experiment 14.-- 
Dose of antigen in millions 
of pneumococcL 
100 +  2,000 +  10,000 
Culture  of 
Pneumococcus 
Type II. 
CO° 
0.00001 
No. of mice.  Died.  Survived. 
The  alcohol-soluble fraction  of the  trypsin digest  of which only a 
very small  amount  was available for  chemical  study contained  but 
little nitrogen (5 rag. per 100 cc. of solution, 1 cc. of which was equiva- 
lent to 80 billion pneumococci), gave a negative biuret test, and posi- 
tive Millon, xanthoproteic,  and ninhydrin tests, showing the presence 
of aromatic  (cyclic) amino-acids,  and the absence of higher polypep- 
tides,  peptone,  and  proteoses.  It  is  generally  conceded  that  the 
amino-acids  and  lower polypeptides  do  not  act  as  antigens  in  any 
sense.  One is forced then to assume that the antigenic factor in the 
alcohol-water-soluble  fraction  is  a  non-protein,  non-lipin  substance. 
That the antigen is not of lipoidal or fatty nature was demonstrated 
by thoroughly extracting  the acid filtrate  of the  trypsin digest with 
ether  for  several  days.  The  alcohol-soluble fraction  of  the  trypsin 
digest  was  treated  in  the  same  manner.  These  lipin-free  antigen 
solutions  conferred  a  degree  of immunity  equal  to  that  of  the  un- 
extracted  antigen  solutions. Y~ILLIA]kl A.  PERLZWEIG  AND  GUSTAV  I.  STEFFEN 
Experiment 15.-- 
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Dose of antigen in 
millions 
of pneumoeoccl. 
100 -{- 5,000 
100 -{- 5,000 
100 -{- 5,000 
Culture. 
CC. 
0.001 
0.01 
0.1 
No. of mice.  Died.  Survived. 
In this connection it may be mentioned that alcohol, ether, chloro- 
form, and acetone extracts were made from intact dried pneumococci, 
and  sodium salts were prepared from the fatty acids of pneumococci 
in  accordance  with  Warden's  method  (11).  Repeated  attempts  to 
immunize mice with these fatty and lipoidal fractions ;failed.  These 
sodium  salts  of  fatty  acids  obtained  from  Pneumococcus  Type  I 
were  dissolved  in  Ringer's  solution  and  cholesterol  was  added. 
Warden found in his experiments that cholesterol reinforces the anti- 
genic value of the bacterial fats. 
Experiment 16.--Six mice were each injected subcutaneously with three doses of 
a solution of a sodium salt of fatty acids from Pneumococcus Type I  reinforced 
with  cholesterol.  The amount given in each injection was 0.5  cc.,  containing 
0.25 mg. of soap and 1 mg. of cholesterol.  At the same time three control mice 
were injected with three doses of a solution  of cholesterol,  each dose  containing 
1 nag. of cholesterol.  9 days after the last injection the vaccinated mice and  the 
control mice were each inoculated intraperitoneally with 0.0000001  cc. of a broth 
culture of virulent Pneumococcus Type I.  All the mice died in 48 hours. 
Experiment 17.--Antigen prepared as in  the preceding experiment.  Feb.  7, 
1921.  Five mice received each 0.5 cc. of the antigen subcutaneously, containing 
1 rag.  of sodium soaps from Pneumococcus Type I  and 1.25 rag.  of  cholesterol. 
The second,  third,  and fourth doses g~ven subcutaneously on Feb.  10,  12,  and 
15  respectively contained  the  same amount of antigen  and  cholesterol  as  the 
first dose.  Feb. 23  (8 days after the last injection).  The five vaccinated  mice 
and a  control mouse were each inoculated intraperitoneally with 0.0000001  cc. 
of a broth culture of virulent Pneumococcus Type I.  All the mice died. 
These experiments show  that  immunity  could not  be  obtained  in 
white mice by subcutaneous injections of salts of fatty acids derived 
from Pneumococcus Type I  even against a  very small infecting dose 
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IV.  Behavior of Pneumococcus Antigen towards Heat,  and Its Keeping 
Qualities. 
Since it was not deemed desirable to introduce  preservatives  and 
the  uncertainty  attendant  upon  their  use  with  antigen  solutions, 
also in order to test the thermostability of the antigen,  the following 
experiments  on  the  effect of  sterilization  by  heat  were  performed. 
Two portions  of  the  acid  filtrate  of  tryptic  digests  of pneumococci, 
which  contained  antigen  as shown in Experiment  9,  were heated  in 
test-tubes of ½ inch diameter for 5  minutes  by immersion  in  boiling 
water.  The reaction in one tube was kept at its original  acidity of 
approximately  pH  6.0,  while  the  contents  of  the  second  tube were 
made alkaline  to pH 9.0 with dilute sodium hydroxide.  In the acid 
solution  a  slight  precipitate  was produced  on  heating,  whereas  the 
alkaline  solution remained  clear.  After cooling, both solutions were 
filtered  through  Mandler  filters  and  clear  filtrates  were  obtained. 
The  acid  filtrate  gave  a  negative  biuret  reaction  and  contained  21 
rag.  of nitrogen per 100 cc., while the alkaline filtrate gave a positive 
biuret reaction and contained 38.5 rag.  of nitrogen per 100 cc.  Four 
mice were used for testing each of these two solutions by the method 
given in preceding experiments. 
Experiment/<?.--Antigen injections 4 days apart.  Inoculation with  pneumo- 
coccus culture 10 days after last dose of antigen. 
Antigen in millions of pneumococci.  Culture.  No. of mice.  Died.  Survived. 
Boiled acid antigen. 
i00 ~  2,000 -}- 10,000 
Boiled alkaline antigen. 
100 q- 2,000 -k 10,000 
CC. 
0.001 
0.001 
This  experiment  shows  that  boiling  the  antigen  solution  for  5 
minutes  in a  slightly acid medium  does not destroy its immunizing 
property, and that boiling the same solution for the same  length  of 
time  but in alkaline  solution appears  to destroy the  antigen.  This 
single experiment  also seems to indicate  that  the  coagulable protein 
occasionally remaining in the tryptic digest is not the antigenic factor. 
In another series of experiments  (Experiments  19  and  20)  an  acid 
filtrate of a  tryptic digest of Pneumococcus Type I  and a  solution of 
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experiments on mice 1 month after preparation.  A portion of each 
solution with a pH of 6.0 was heated in a water bath at 56°C. for 1 
hour.  The heated and  the unheated solutions were  then left in  a 
refrigerator at 4°C. without any preservative for 2½ months and at the 
end of that period their antigenic power was again tested on mice. 
In each step of these two experiments the mice received the same 
quantity of antigen in the same number of doses.  Three doses were 
given 4 days apart.  The amounts given were the equivalents of 50, 
2,000, and 10,000 million respectively of killed Pneumococcus Type I. 
10 days after the last injection of antigen the mice were inoculated 
intraperitoneally with a  culture of virulent Pneumococcus Type I. 
Experiment 19.-- 
Antigen. 
Acid filtrate of tryptic digest, kept 1 too. 
"  "  "  "  "  heated  at 
56°C. for 1 hr.  and  kept for 2½ mos. 
after heating. 
Acid filtrate of tryptic digest, unheated, 
kept for 3½ mos. 
Culture. 
CO. 
0.000001 
0.00001 
0.0001 
0.000001 
0.00001 
0.0001 
0.000001 
0.00001 
0.0001 
No. 
of mice. 
6 
3 
3 
6 
3 
3 
5 
3 
3 
Died.  Survived. 
Experiment 20.-- 
/mtisen. 
Alcohol-soluble fraction of tryptic digest, 
kept 1 too. 
Alcohol-soluble fraction of tryptic digest, 
heated  at  56°C.  for  1  hr.  and  kept 
for 2½ mos. after heating. 
Alcohol-soluble fraction of tryptic digest, 
unheated, kept for 3½ mos. 
Culture. 
0.000001 
0.00001 
0.0001 
0.000001 
0.00001 
0.0001 
0.000001 
0.00001 
0.0001 
NO. 
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These  experiments  demonstrate  that  the  slightly acid  antigenic 
solutions may be kept in the refrigerator for at least 3  months and 
that they may be heated for fully 1 hour at 56°C.  without deteriora- 
tion or decrease in their immunizing property.  The question of the 
duration of the immunity produced in mice by the various antigens 
is being investigated. 
After the procedure for extracting the antigen had been worked out 
it was observed that it resembled in many respects that of Wildiers' 
(12)  for the preparation of his now classic bios, or growth-promoting 
factor in yeast, especially as regards resistance to autolyfic digestion 
and solubility in 80 per cent alcohol.  This analogy suggested experi- 
ments which were carried out with some of the antigenic solutions. 
Experiment 21.--0.00000001 cc. (in 1 cc.) of an 18 hour plain broth culture of 
Pneumococcus Type I was added to each of two tubes containing 10 cc. of plain 
broth and 0.2 cc. of pneumococcus antigen.  Two tubes, each containing 10 cc. 
of plain broth and 0.2 cc. of 0.9 per cent NaC1 were inoculated with 0.00000001 
cc. of the culture at the same time and acted as controls.  All the tubes were 
incubated for 6 hours at 37.5°C.  At the end of this period the growth was de- 
termined by pouring blood agar plates  with  1 cc.  of  the  culture and  colony 
count after 18 hours incubation. 
Plate No.  Culture and antigen.  Colonies. 
1  0.00000001 cc. of  culture with 0.2 cc. of  antigen.  415 
2  0.00000001  "  "  "  "  0.2  "  "  "  620 
3  0.00000001  "  "  "  "  0.2  "  "  saline.  4 
4  0.00000001  "  "  "  "  0.2  "  "  "  15 
The experiment was repeated with the same Pneumococcus Type 
I  antigen  with  0.0000001  cc.  of  a  broth  culture  of  Pneumococcus 
Type II,  also with 0.000001  cc.  of a  broth  culture of Streptococcus 
hcemolyticus.  In  both  instances  the  same  remarkable  growth- 
promoting effect was  observed.  While the number of observations 
on this phase of our work is still insufficient to warrant definite con- 
clusions,  the few experiments described indicate that a  non-specific 
growth-promoting  agent  for  bacteria  is  extracted  along  with  the 
antigen.  This  interesting  similarity  of  two  apparently  different 
biological agents may lead to a  clearer understanding of the ultimate 
chemical nature of bacterial antigen.  Further research on this aspect 
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V. Experiments with Antigens Prepared  from Pneumococcus Types H 
and I H. 
From the experiments which have been presented above it will be 
seen that water-soluble extracts of pneumococcus antigen can readily 
be prepared from Pneumococcus Type I  by several different methods. 
It seemed desirable  to determine whether similar  antigens  could be 
prepared  from  the  other  two  fixed  types of pneumococcus.  In  the 
following  experiment  the  antigen  was  prepared  from  a  virulent 
Pneumococcus Type II. 
Experiment 22.--White mice were injected subcutaneously with a  saline  sus- 
pension  of Pneumococcus  Type II killed  by heating at 60°C.  for 1 hour.  Six 
mice were injected subcutaneously each with 100 million  (0.5 cc.) Pneumococcus 
Type II saline vaccine.  6 days later the mice received each 1,000 million (0.5 cc.) 
Pneumococcus Type II saline vaccine.  11 days after the second injection the six 
vaccinated mice  and  two  control mice  were each inoculated intraperitoneally 
with a broth culture of virulent Pneumococcus Type II. 
No. of mice.  Culture.  Died.  Survived. 
3 
3 
1 (control). 
1  (  "  ). 
O. 00001 
0.001 
O. 00000001 
O. 0000001 
The results of this experiment show that immunity against Pneumo- 
coccus Type II can be obtained by two subcutaneous injections of a 
saline suspension of killed Pneumococcus Type II.  In the following 
experiment an antigen consisting of an acid filtrate of tryptic digest 
of Pneumococcus Type II was used.  The antigen was prepared from 
a  portion of the same suspension of Pneumococcus Type II that was 
used in Experiment 22. 
Experiment 23.--Six mice were each injected subcutaneously with three doses 
of antigen at 4 day intervals.  The amounts given were the equivalents respec- 
tively of 100, 2,000, and 10,000 million killed pneumococci.  2 days after the last 
injection of antigen three of the vaccinated mice and control mice were inoculated 
intraperitoneally with a broth culture of virulent Pneumococcus  Type II.  The 
remaining three vaccinated mice and control mice received  the virulent culture 
on the 6th day after the last dose of antigen. 178  STUDIES  ON PNEUMOCOCCUS  IMMUNITY.  III 
Period after last dose  Culture.  No. of mice.  Died.  Survived. 
of antigen. 
days 
2 
6 
Control. 
*c 
CO. 
0.00001 
0.0001 
0.OOOOOOO1 
O. 0000001 
0.000001 
Experiment 24.--In  this experiment the alcohol-soluble  fraction of a  tryptic 
digest  of Pneumococcus Type n  was  used as  an  antigen.  Six mice received 
each  three  doses  of  this  antigen  subcutaneously.  The  injections were given 
3 to 4 days apart and the amounts were the equivalents of 100, 2,000, and 10,000 
million respectively of killed pneumococci.  6 days after the last injection of the 
antigen three of the vaccinated mice with controls  were  inoculated  intraperi- 
toneally with  a  culture of  virulent  Pneumococcus  Type  n.  The  remaining 
three  vaccinated  mice  were  inoculated  intraperitoneally  with Pneumococcus 
Type n  11 days after the last dose of antigen. 
Period after last 
dose of antigen.  Culture.  No. of mice.  Died.  Survived. 
days 
6 
11 
Control. 
CC. 
O. 00001 
O. 0001 
0.00000001 
0.0000001 
2 
1 
0 
0 
Experiments 23 and 24 show that the  filtrates of trypsin digests of 
Pneumococcus  Type  II  and  the  alcohol-soluble  fraction  of  these 
digests confer immunity in mice against Pneumococcus Type II. 
Finally, the antigenic power of Pneumococcus Type III was, studied. 
The  first  experiments  with  antigens  from  Pneumococcu__s Type  III 
were  carried out with  saline suspensions  of killed pneumococci. 
Experiment 25.--Twelve mice were each injected subcutaneously with  three 
doses of a saline suspension if Pneumococcus Type III, killed by heating at 60°C. 
for 1 hour.  The injections were given 4 days apart, the doses being 100, 1,000, 
and 2,000 million  respectively.  10 days after the last injection of vaccine the 
mice  and  controls were  inoculated  intraperitoneally with  a  broth  culture  of 
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No. of mice. 
3 
3 
3 
2 
2 (control). 
2(  "  ). 
Culture. 
CC. 
0.000001 
0.00001 
0.0001 
0.001 
0.00000001 
0.0000001 
Died.  Survived. 
This experiment shows that a  definite immunity can be obtained 
against Pneumococcus Type III by three subcutaneous injections of 
the  saline  suspension.  In  the  following  experiment  the  antigen 
used was an alcoholic extract of a  trypsin digest of Pneumococcus 
Type III prepared according to the technique described previously. 
Experiment  26.--Six mice were each injected subcutaneously with thre~ doses 
of an alcoholic extract of a  trypsin digest of  Pneumococcus Type III antigen. 
The injections were given at intervals of 4 days and the quantities injected were 
equivalent to  50,  500,  and  5,000  million respectively of  killed  pneumococci. 
7 days after the last injection of antigen the treated mice and control mice were 
inoculated  intraperitoneally with  a  broth  culture  of  virulent  Pneumococcus 
Type III. 
No. of mice.  Culture.  Died.  Survived. 
3 
3 
1 (control). 
1  (  "  ). 
0.000001 
0.0001 
0.00000001 
0.0000001 
As in  the case  of Pneumococcus Types I  and II,  so with Pneu- 
mococcus Type III,  an alcoholic extract of a  trypsin digest of the 
bacteria  conferred an  immunity against  the  homologous type,  ap- 
proximately as high as that obtained by the original saline vaccine. 
DISCUSSION. 
From the experiments which have been reported in this paper it is 
clear that the immunizing antigen can be isolated from the three fixed 
types of pneumococcus by comparatively simple chemical methods. 180  STUDIES  ON  PNEUMOCOCCUS  IMMUNITY.  III 
This antigen in its purified form contains only a  trace  of nitrogen. 
In the alcoholic extract of a tryptic digest the nitrogen determination 
showed only 5 mg. of nitrogen per 100 cc. of antigen. 
While on the basis of the reported experiments it cannot be definitely 
stated that the immunizing antigen is non-protein in nature, the evi- 
dence presented points strongly in that direction.  The solubility in 
90 per cent alcohol taken in  conjunction with the remarkable heat 
stability  and  the  resistance  to  the prolonged action  of proteolytic 
enzymes does establish beyond reasonable doubt that the substance 
is much simpler in nature than the large and complex molecule of 
native bacterial protein. 
It will be recalled in this connection that the purified pneumococcus 
antibody obtained recentlybyHuntoon (13) possessed similar chemical 
properties.  The only notable bacterial antigen possessing properties 
almost identical with those of our antigen is the "Coagulin B,"  ob- 
tained by Pick (14),  which was a  saline extract of young cultures of 
typhoid bacilli.  It gave a  specific precipitate with homologous im- 
mune serum,  was  protein-free,  soluble  in  alcohol,  and  resistant  to 
heat and to proteolytic enzymes.  This striking parallel came to the 
attention  of  the  authors  after  the  completion of  the  experimental 
work herein described and it served to strengthen their belief in the 
non-protein nature of the immunizing pneumococcus antigen. 
The chemical data pertaining to the constitution of the antigen are 
mainly negative, resembling in this respect the findings concerning the 
ultimate composition of two other large classes of biological agents, 
the  ferments  and  the  vitamines.  But  unlike  these  last  two  the 
chemistry of the bacterial antigens has not been subjected to intensive 
study. 
The  relation  which  the  immunizing antigen  described  in  these 
experiments may bear to the other antigens contained in the pneumo- 
coccus,  e.g.  precipitinogen, agglutinogen,  and  complement fixation 
ant,igen, is of obvious interest, and the authors hope to report some 
interesting data on this subject in .the near future.  The recent study 
by Zinsser and Parker  (15)  renders the further investigation of the 
relation existing between the various antigens all the more interesting 
and  urgent.  It  is  quite  significant that  the  antigen  extracted  by 
Zinsser and Parker from pneumococci by weak alkaline solutions and WILLIAM  A. PERLZWEIG  AND  GUSTAV  I. STEFFEN  18[ 
deproteinized by  acidification and  heat yielded a  non-protein sub- 
stance,  similar  to  Pick's  "coagulin" (14),  which produced specific 
precipitates with homologous serum, but on the other hand produced 
no antibodies when injected into  animals.  It is  to  be  noted  that 
while this substance resembled the antigen described in the present 
paper in its resistance to heat, it differed from it in being precipitable 
by  alcohol.  The  immunizing antigen  herein  described  was  freely 
soluble in 90 per cent alcohol and the alcohol-insoluble fraction after 
careful washing with 90 per cent alcohol contained no immunizing 
antigen  (Experiment  12).  These results  strongly suggest that  the 
precipitinogen and the immunizing antigen are distinct entities.  It 
may be stated that among the various antigenic solutions tested with 
immune serum the writers found a  number which produced specific 
precipitates yet failed to immunize mice; on the other hand, some of 
the  potent  alcohol-soluble  immunizing antigens  failed  to  produce 
precipitates with homologous serums. 
These purified pneumococcus antigens are non-toxic for mice and 
could probably be used in comparatively large doses in man without 
exciting severe local or general reactions, 
CONCLUSIONS. 
1.  Active immunity against many lethal doses of Pneumococcus 
Types I, II, and III may be produced in mice by two or three sub- 
cutaneous injections of the homologous type of pneumococcus saline 
vaccine. 
2.  Mice may be actively immunized with the protein fraction ob- 
tained by treating pneumococci with anhydrous sodium sulfate or by 
solution of pneumococci in bile salts and precipitation with alcohol. 
Pneumococcus antigen is therefore carried within or adheres to  the 
protein fraction of the organism. 
3.  Pneumococcus antigen is  resistant  to  prolonged autolysis and 
to tryptic digestion, and can be recovered from the soluble portions 
of digests of either the intact bacteria or the bacterial protein. 
4.  The antigen may be isolated from each of the three fixed types 
of pneumococcus by tryptic digestion of the pneumococci and extrac- 
tion of the digest with 70 to 90 per cent alcohol.  The antigen is not 
soluble in absolute alcohol, nor is it soluble in ether or in the other 
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5.  The immunizing  property of slightly acid solutions of the antigen 
is not impaired by boiling for 5 minutes, nor by heating at 56°C. for 
1 hour.  Sterile unpreserved solutions of the antigen did not deter- 
iorate by standing in the refrigerator for 3½ months. 
6.  The exact chemical nature of pneumococcus antigen still remains 
to be determined.  From the experiments reported it appears  that 
the antigen is non-lipoidal, that it probably adheres to the protein 
fraction in a loose chemical or physical union rather than representing 
a protein complex of a large molecular size, as shown by its solubility 
in  alcohol,  its  thermostability,  and  its  resistance  to  proteolytic 
digestion. 
7.  Some of the antigens studied have been shown to contain a non- 
specific factor promoting the growth of bacteria. 
8.  The purified pneumococcus antigen solutions are non-toxic for 
mice. 
BIBLIOGRAPHY. 
1.  Cecil, R. L., and Steffen, G. I., J. Exp. Med., 1921, xxxiv, 245; 1923, xxxviii, 149. 
2.  Wadsworth, A. B., J. Iminunol., 1920, v, 429. 
3.  Much, I-I., Manch. reed. Woch,, 1920, lxvii, 1005. 
4. Rowland, S., J. Hyg., 1912, xi, suppl. 1, pp. 11, 20; xii, suppl. 2, pp. 340, 344, 
350, 358; 1914, xiil, suppl. 3, pp. 403,418, 440. 
5. Rosenow, E. C., J. Infect.  Dis., 1911, ix, 190; 1912, x, 113; 1912, xi, 94, 235, 
286; J. Am. Med. Assn., 1918, lxx, 759. 
6.  Jobling, J. W., and Strouse, S., J. Exp. Med., 1912, xvi, 860. 
7.  Hirschfelder, J. 0., J. Am. Med. Assn., 1912, lix, 1373. 
8.  Osborne,  T.  B.,  Mendel, L.  B.,  and Harris,  I.  F., Am.  J.  Physiol.,  1905, 
xiv, 259. 
9.  Greenwald, I., J. Biol. Chem., 1915, xxi, 61. 
10.  Folin, O.,  and Farmer, C. J., J. Biol. Chem., 1912, xi, 493. 
11.  Warden, C. C., J. Infect,. Dis., 1918, xxii, 133; xxiii, 504; 1919, xxiv, 285. 
12.  Wildiers, La Cellule, 1900, xvii, 385. 
13. Huntoon, F. M., J. Immunol., 1921, vi, 117.  Huntoon, F. M., and Etris, S., 
,1. Immunol., 1921, vi, 123.  Huntoon, F. M., Masucci, P., and Hannum, 
E., J. Immunol., 1921, vi, 185. 
14.  Pick,  E.  P.,  Beitr.  chem. Physiol.  u.  Path.,  1902,  i,  397;  also  discussed in 
detail by Paltauf (Paltauf, R.,  in  Kolle,  W.,  and  von Wassermann, A., 
Handbuch tier pathogenen Mikroorganismen,  Jena,  2nd edition, 1913, ii, 
567). 
15.  Zinsser, H., and Parker, J. T., J. Exp. Med., 1923, xxxvii, 275. 